456 related articles for article (PubMed ID: 29178862)
1. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
Shaikh MH; Khan AI; Sadat A; Chowdhury AH; Jinnah SA; Gopalan V; Lam AK; Clarke DTW; McMillan NAJ; Johnson NW
BMC Cancer; 2017 Nov; 17(1):792. PubMed ID: 29178862
[TBL] [Abstract][Full Text] [Related]
2. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.
Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F;
J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521
[TBL] [Abstract][Full Text] [Related]
3. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
[TBL] [Abstract][Full Text] [Related]
4. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
6. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
[TBL] [Abstract][Full Text] [Related]
7. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia.
Bhosale PG; Pandey M; Desai RS; Patil A; Kane S; Prabhash K; Mahimkar MB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Nov; 122(5):609-618.e7. PubMed ID: 27765330
[TBL] [Abstract][Full Text] [Related]
10. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and genotypes of human papillomavirus in saliva and tumor samples of head and neck cancer patients in Hungary.
Hettmann A; Demcsák A; Bach Á; Decsi G; Dencs Á; Pálinkó D; Rovó L; Terhes G; Urbán E; Buzás K; Nagy K; Takács M; Minarovits J
Infect Genet Evol; 2018 Apr; 59():99-106. PubMed ID: 29408738
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Diagnostic Utility of a High-Risk Human Papillomavirus PCR Test on Formalin-Fixed, Paraffin-Embedded Head and Neck Tumor Tissues.
Huho AN; Yadak N; Bocklage TJ; Yang S
J Mol Diagn; 2018 Mar; 20(2):232-239. PubMed ID: 29277636
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy.
Baboci L; Holzinger D; Boscolo-Rizzo P; Tirelli G; Spinato R; Lupato V; Fuson R; Schmitt M; Michel A; Halec G; Da Mosto MC; Pawlita M; Del Mistro A
Papillomavirus Res; 2016 Dec; 2():133-140. PubMed ID: 29074172
[TBL] [Abstract][Full Text] [Related]
14. HPV-associated head and neck cancers in the Asia Pacific: A critical literature review & meta-analysis.
Shaikh MH; McMillan NA; Johnson NW
Cancer Epidemiol; 2015 Dec; 39(6):923-38. PubMed ID: 26523982
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx].
Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A
Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
[TBL] [Abstract][Full Text] [Related]
17. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
Dreyer JH; Hauck F; Barros MHM; Niedobitek G
Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
[TBL] [Abstract][Full Text] [Related]
18. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
[TBL] [Abstract][Full Text] [Related]
19. Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients.
Sannigrahi MK; Singh V; Sharma R; Panda NK; Radotra BD; Khullar M
Oral Dis; 2016 Jan; 22(1):62-8. PubMed ID: 26475514
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?
Klussmann JP; Weissenborn SJ; Wieland U; Dries V; Eckel HE; Pfister HJ; Fuchs PG
Med Microbiol Immunol; 2003 Aug; 192(3):129-32. PubMed ID: 12920586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
